Gain on sale margin increased to 113 basis points, up 19 basis points from Q1 2025.
MSR portfolio stood at $211.2 billion UPB with a weighted average coupon of 5.51%.
Net income was $314.5 million, including a $111 million decline in fair value of MSRs.
Purchase originations totaled $27.3 billion, marking the third-best purchase quarter ever and tracking to over $100 billion for the year.
Refinance volume doubled year-over-year to $12.4 billion, representing about 11% of the industry volume despite owning only 2% of the servicing market.
Total equity increased to $1.7 billion and cash position was $490 million with total available liquidity of $2.2 billion.
UWM reported $39.7 billion in production volume for Q2 2025, the best quarter since 2021 and nearly 20% higher than Q2 2024.
Strategic Exit from Global Reinsurance Business and Capital Reallocation
Markel announced the decision to sell renewal rights and cease writing new business in its global reinsurance operation, which was acquired through Alterra over 10 years ago.
This move is aimed at focusing on core lines of business and improving profitability.
The exit is expected to free up capital, with the reserves and investments continuing to generate returns, and will provide flexibility for reinvestment.
The sale of renewal rights will result in premiums being earned over the next 2-3 years, with some renewal contracts processed in Q3 2025.
Management highlighted the potential for capital release and optionality, with a focus on reinvesting proceeds strategically.